ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients
Clinical trial NCT00170846 · COMPLETED
Trial details
- NCT number
- NCT00170846
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.